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Objective: C-reactive protein (CRP) levels can be elevated in osteoarthritis (OA) patients. In addition to
indicating systemic inﬂammation, it is suggested that CRP itself can play a role in OA development.
Obesity and metabolic syndrome are important risk factors for OA and also induce elevated CRP levels.
Here we evaluated in a human CRP (hCRP)-transgenic mouse model whether CRP itself contributes to the
development of ‘metabolic’ OA.
Design: Metabolic OA was induced by feeding 12-week-old hCRP-transgenic males (hCRP-tg, n ¼ 30) and
wild-type littermates (n ¼ 15) a 45 kcal% high-fat diet (HFD) for 38 weeks. Cartilage degradation,
osteophytes and synovitis were graded on Safranin O-stained histological knee joint sections. Inﬂam-
matory status was assessed by plasma lipid proﬁling, ﬂow cytometric analyses of blood immune cell
populations and immunohistochemical staining of synovial macrophage subsets.
Results: Male hCRP-tg mice showed aggravated OA severity and increased osteophytosis compared with
their wild-type littermates. Both classical and non-classical monocytes showed increased expression of
CCR2 and CD86 in hCRP-tg males. HFD-induced effects were evident for nearly all lipids measured and
indicated a similar low-grade systemic inﬂammation for both genotypes. Synovitis scores and synovial
macrophage subsets were similar in the two groups.
Conclusions: Human CRP expression in a background of HFD-induced metabolic dysfunction resulted in
the aggravation of OA through increased cartilage degeneration and osteophytosis. Increased recruitment
of classical and non-classical monocytes might be a mechanism of action through which CRP is involved
in aggravating this process. These ﬁndings suggest interventions selectively directed against CRP activity
could ameliorate metabolic OA development.
© 2018 The Authors. Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Osteoarthritis (OA) is a progressive joint disease of partially
unknown aetiology that is characterised by focal loss of articular
cartilage. In humans the most signiﬁcant factor contributing to OA
is overweight, leading to an OA phenotype here referred to as. Stoop, TNO, Zernikedreef 9,
r Ltd on behalf of Osteoarthritis Re
d/4.0/).
et al., Human C-reactive prot
oi.org/10.1016/j.joca.2018.09‘metabolic OA’. In recent years there has been increasing emphasis
on the systemic, metabolic components involved in the develop-
ment and progression of this OA phenotype1e3. There is mounting
evidence that metabolic overload and related systemic inﬂamma-
tory mediators are associated with OA development and progres-
sion. This led to the recognition of a clinically distinct OA
phenotype, termed metabolic OA4. Especially the systemic low-
grade chronic inﬂammation, which is strongly associated to
metabolic overload5, is thought to play an important role in the
local development and progression of metabolic OA3,4.search Society International. This is an open access article under the CC BY-NC-ND
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A.E. Kozijn et al. / Osteoarthritis and Cartilage xxx (2018) 1e112Metabolic overload-induced systemic inﬂammation as seen in
humans can be induced by prolonged high-fat diet (HFD) feeding in
small animal models and has been shown to aggravate metabolic
OA development in these models6. We have previously demon-
strated in various obesity-prone mouse strains that HFD feeding
alone does not necessarily lead to aggravated articular cartilage
degradation and suggested that an additional trigger besides high-
caloric feeding is necessary to evoke metabolic OA7. In a study by
Gierman et al.8, this human C-reactive protein-transgenic (hCRP-tg)
strain was used to easily monitor the systemic inﬂammatory status
of the mice via the general inﬂammation marker CRP. Aggravated
OA pathology was observed in hCRP-tg male mice fed with a HFD
(45 kcal% energy from fat) compared with chow diet. As these mice
received a HFD without an additional trigger, it is conceivable that
CRP itself might have triggered the aggravated OA pathology.
Moreover, low-grade inﬂammation proved more important than
mechanical overload in the development of HFD-induced meta-
bolic OA in the hCRP-tg mouse8. Anti-inﬂammatory intervention
with either cholesterol-lowering rosuvastatin or PPARg agonist
rosiglitazone showed signiﬁcant suppression of both OA develop-
ment as well as plasma CRP levels, supporting the importance of
inﬂammation in metabolic OA pathogenesis.
CRP involvement has also been suggested in human OA patho-
genesis. Systemic CRP levels are signiﬁcantly elevated in OA pa-
tients compared with healthy controls and have been reported to
relate with clinical features and radiographic severity9e12. The
population-based Chingford study conﬁrmed these ﬁndings and
the authors suggested that CRP levels in early OA can be used as a
predictive marker for disease progression13. In patients with
advanced OA, systemic CRP levels reﬂected local joint inﬂamma-
tion14 or pain15 rather than radiographic OA. The latter ﬁnding was
corroborated by a recent meta-analysis of 32 studies, where CRP
levels were signiﬁcantly associated with pain and decreased
physical function but not radiographic OA16. In contrast, others
demonstrated no association between CRP levels and OA severity
after adjustment for body mass e including the follow-up of the
Chingford study17e20. These contradictory results between studies
have clouded the association between CRP levels and OA pathology.
In our present study, we aimed to elucidate the role of CRP in
HFD-induced OA pathogenesis. Male hCRP-tg mice were compared
with their wild-typemale littermates on a HFD to infer whether the
expression of CRP contributed to diet-induced OA aggravation. OA
features like osteophyte formation and synovitis were determined
to investigate involvement with different aspects of OA pathology.
Systemic lipid proﬁles, blood immune cell populations and synovial
macrophage subsets were evaluated to assess whether hCRP-tg
mice had a more proinﬂammatory status relative to their wild-
type littermates.Methods
A detailed methods section is available in the Online
Supplemental File.Mice and experimental design
The experiment was carried out in male human CRP-transgenic
(hCRP-tg, n ¼ 30) and male wild-type littermates (n ¼ 15) on a
C57BL/6J background. Metabolic OA was induced by switching the
diet of the mice from standard chow to a high-fat diet (HFD, 45 kcal
% from fat; cat# D12451, Research Diets Inc., New Brunswick, USA)
at 12 weeks of age. Both groups received the HFD for a consecutive
period of 38 weeks. The experiment was approved by the institu-
tional Animal Care and Use Committee of TNO and was inPlease cite this article in press as: Kozijn AE, et al., Human C-reactive prot
Osteoarthritis and Cartilage (2018), https://doi.org/10.1016/j.joca.2018.09compliance with ARRIVE guidelines and European Community
speciﬁcations regarding the use of laboratory animals.
Analysis of metabolic dysfunction and OA
Metabolic dysfunction was monitored at regular interval during
the study period by assessing body weight gain, changes in body
composition (EchoMRI LLC, Houston, TX, USA), fasted plasma total
cholesterol, glucose and insulin levels. Fasted plasma CRP levels
were determined by sandwich ELISA (cat.no. DY1707, R&D Systems,
USA). Insulin resistance index (HOMA-IR) was calculated according
to the equation proposed byMatthews et al.21: HOMA-IR¼ (glucose
(mmol/L)  insulin (mU/L))/22.5.
Articular cartilage degradation, osteophyte formation and syno-
vitis were scored on coronal 5 mm knee joint sections, stained with
Haematoxylin, Fast Green and Safranin-O, according to OARSI his-
topathology initiative recommendations for the mouse22. For all
grades,we report the sumof themedial and lateral compartments as
the total score. Please see Supplemental Methods for more details.
Lipid and oxylipin analyses in fasted plasma
Samples were stored at 80C before analysis. General lipid
proﬁles were determined at time points t¼ 0weeks, t¼ 4 days after
HFD switch (peak in hCRP plasma levels) and t ¼ 38 weeks. Oxy-
lipin proﬁling was performed at t ¼ 0, 14 and 38 weeks, due to
deﬁcient sample volumes at the intermediate blood collection at
t ¼ 4 days. Sample volumes of 5 ml and 50 ml were aliquoted from
each fasted plasma sample for general lipid/free fatty acids (FFAs)
analysis and oxylipin analysis, respectively. Please refer to the
Supplemental Methods for a more detailed method description.
The lipidomic datasets analysed during the current study are also
stored in a phenotype database repository and are available by
signing up via https://dashin.eu/interventionstudies/. After
receiving credentials and logging in, the study can be accessed via
https://dashin.eu/interventionstudies/study/show/39162914 or by
searching the study code (hCRP_in_mouse) or study title (“Human
C-reactive protein aggravates osteoarthritis development in mice
on a high-fat diet”).
Immunophenotyping of peripheral cell populations by ﬂow
cytometry
Peripheral myeloid and lymphoid populations were analysed by
ﬂow cytometry at three different time points (t ¼ 2/11/37 weeks).
Peripheral blood (5 drops/animal) was drawn via tail incision using
lithium heparin-coated Microvette tubes. Cell-surface staining was
performed with the myeloid and lymphoid antibody panels shown
in Tables I and II. Pooled samples were used for unstained, single-
stained and FMO controls to determine background levels of
staining. Data were acquired with a 3-laser FACSCanto™ II ﬂow
cytometer (Becton Dickinson) (Supplemental Table S2) and ana-
lysed using FlowJo v10.2 (Treestar Inc., USA). Cell populations of
interest were gated according to the gating strategies as depicted in
Supplemental Figs. S3 and S4, to obtain their population fre-
quencies. Baseline population frequencies were determined in age-
matched hCRP-tg (n ¼ 5) and wild-type (n ¼ 4) males from later
litters and were not included in the statistical analysis (shown here
in grey). Detailed descriptions are included in the Supplemental
Methods.
Immunohistochemical evaluation of macrophage subsets in the knee
Knee joints from both groups were stained with chromogenic
triple-labelling immunohistochemistry (IHC) for M1 and M2ein aggravates osteoarthritis development in mice on a high-fat diet,
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Table I
Antibody panel used for the analysis of peripheral myeloid subpopulations
Marker Fluorochrome Dilution Clone Manufacturer Catalogue number
CCR2 FITC 1:100 475301 R&D Systems FAB5538F
MHCII PE 1:100 M5/114.15.2 BD Biosciences 557000
CD11c PE/Cy7 1:100 N418 eBioscience 25-0114
GR1 PerCP/Cy5.5 1:100 RB6-8C5 BD Biosciences 552093
CD86 APC 1:100 GL1 BD Biosciences 558703
F4/80 APC/Cy7 1:200 BM8 BioLegend 123118
CD11b Horizon V450 1:100 M1/70 BD Biosciences 560455
Abbreviations: FITC, ﬂuorescein isothiocyanate; PE, phycoerythrin; Cy, cyanine; PerCP, peridinin chlorophyll protein complex; APC, allophycocyanin.
Table II
Antibody panel used for the analysis of peripheral lymphoid subpopulations
Marker Fluorochrome Dilution Clone Manufacturer Catalogue number
CD8a FITC 1:100 53e6.7 BD Biosciences 553031
CD4 PE 1:100 RM4-4 eBioscience 12-0043-83
CD62L PE/Cy7 1:100 MEL-14 eBioscience 25-0621-82
CD45 PerCP/Cy5.5 1:100 30-F11 BD Biosciences 550994
CD25 APC 1:100 PC61.5 eBioscience 17-0251-81
CD3e APC/Cy7 1:200 145-2C11 BD Biosciences 557596
CD19 Horizon V450 1:1000 1D3 BD Biosciences 560375
Abbreviations: FITC, ﬂuorescein isothiocyanate; PE, phycoerythrin; Cy, cyanine; PerCP, peridinin chlorophyll protein complex; APC, allophycocyanin.
A.E. Kozijn et al. / Osteoarthritis and Cartilage xxx (2018) 1e11 3macrophage subsets, based on a previously described method for
human tissue23. Primary antibodies targeted murine macrophages
(F4/80, 1:100, MF48000 (BM8), Invitrogen), M1 macrophages
(iNOS, 1:400, ab136918 (K13-A), Abcam) and M2 macrophages
(CD206, 1:100, AF2535, R&D Systems). Quantiﬁcation was per-
formed in the lateral patellofemoral synovial lining of the knee
joint. Digital images of the unmixed colour spectra for each chro-
mogen in the region of interest (ROI) were obtained with a Nuance
multispectral imaging system (40 magniﬁcation). Macrophage
subtypes were analysed using ImageJ 1.51n image analysis soft-
ware. Colocalization of two or the three markers was calculated
from the areal overlap between positivity for F4/80 and CD206 or
iNOS or both. Data are expressed as percentage positivity for a label
or combination of labels within the ROI or within the F4/80þ
macrophage population. Please see Supplemental Methods for
more details.
Statistical analysis
Statistical analysis was performed using Prism (v7.01, GraphPad
Software, La Jolla, CA, USA) and IBM SPSS software (v25.0, IBM SPSS
Inc., Chicago, IL, USA). Please refer to the statistical analysis section
in the Supplemental Methods for a more detailed description.
Results
Increased cartilage degeneration and osteophytosis in hCRP-tg mice
To assess whether human CRP itself plays a role in the devel-
opment of metabolic OA, male hCRP-tg mice were compared with
their wild-type male littermates on a HFD. Chow controls were not
included in our study, as previous work by our group8 has shown
that hCRP-tg male mice on a HFD had signiﬁcantly higher OA
grades than mice on chow.
Increases in body weight due to fat accumulation, plasma
cholesterol and HOMA-IR reﬂect a state of metabolic dysfunction in
both hCRP-tg and wild-type mice (Supplemental Fig. S1). Expres-
sion of CRP was validated at the protein level in fasted plasma from
hCRP-tg males, whereas wild-type controls were negative. HFD
feeding induced changes at the CRP protein level as observedPlease cite this article in press as: Kozijn AE, et al., Human C-reactive prot
Osteoarthritis and Cartilage (2018), https://doi.org/10.1016/j.joca.2018.09before8. Directly after diet switch, HFD provoked a steep increase in
CRP levels in hCRP-tgmales followed by a gradual decrease over the
course of the study (Supplemental Fig. S2(A)).
Human CRP-tg males showed increased articular cartilage ﬁ-
brillations and vertical clefts with loss of surface lamina [Fig. 1(A)
and (B)]. Cartilage erosion was only seen at the lateral knee com-
partments and almost exclusively occurred in the hCRP-tg group.
Total OA scores demonstrated a signiﬁcant difference between both
groups, with a median [interquartile range] of 4.25 [3.72e5.44] in
wild-type vs 6.00 [4.69e7.26] in hCRP-tg males, P < 0.01, d ¼ 0.818,
95% CI [0.06e0.57] [Fig. 1(B)]. This difference in severity between
groups was primarily visible at the lateral side of the knee joint
with 2.38 [1.69e3.10] in wild-type vs 4.00 [2.82e5.00] in hCRP-tg,
P < 0.01, d ¼ 1.066, 95% CI [0.16e0.69].
Osteophyte formation was distinctly more present in hCRP-tg
mice (3.00 [2.00e5.00]) compared with wild-type controls (2.00
[1.00e4.00]. Fig. 1(C)), P ¼ 0.03, d ¼ 0.46, 95% CI [0.12 to 0.68].
Synovitis scores were comparable between both groups [Fig. 1(D)],
with P ¼ 0.28, d ¼ 0.10, 95% CI [0.32 to 0.44].
The relative individual induction of CRP levels at 4 days after
diet switch did not associate with the individual OA grades at end
point [Supplemental Fig. S2(B)], unlike observed before8. Individual
OA grades reﬂecting cartilage degeneration did not associate to the
individual osteophyte and synovitis scores [Supplemental Fig. S2(C)
and (D)]. Changes in CRP levels within the hCRP-tg group showed
no association to osteophyte or synovitis scores (data not shown).Lipid metabolism comparable between genotypes
Strong diet-induced effects were observed for nearly all
measured lipids, showing predominantly increased concentrations
in plasma over time. Uni- and multivariate statistical analyses
revealed no differences in general lipid and oxylipin proﬁles be-
tween hCRP-tg and wild-type males, neither per time point nor
over time (data not shown). Furthermore, none of the measured
lipids correlated with OA severity within the hCRP-tg group.
Lysophosphatidylcholines (LPC) to phosphatidylcholines (PC) ratio,
as a general indicator of inﬂammatory status and possible predictor
of advanced knee OA in humans24, dropped shortly after HFD
switch (hCRP-tg: from 0.83 [0.62e1.10] to 0.70 [0.38e0.80]; wild-ein aggravates osteoarthritis development in mice on a high-fat diet,
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Fig. 1. HFD feeding aggravates OA progression in hCRP-tg mice. A) Representative coronal sections of the lateral and medial tibiofemoral compartments, stained with Fast-Green/
Safranin-O, from hCRP-tg and wild-type littermates fed a HFD. Chow controls were not included in our study, but hCRP-tg males are known to not develop OA on a feeding regime of
38 weeks8. Magniﬁcation for all microphotographs was 40. B) Summed histopathological scores for the tibiofemoral knee compartments of the hCRP-tg and wild-type groups. C)
Total osteophyte scores showing the individual summed score for the tibiofemoral knee compartments for each animal per study group. D) Total synovitis scores showing the
individual summed score for the tibiofemoral knee compartments for each animal per study group. BeD) Scoring was performed according to OARSI histopathology recom-
mendations for the mouse22. Data are presented as group medians (indicated by bars) with IQR (error bars).
A.E. Kozijn et al. / Osteoarthritis and Cartilage xxx (2018) 1e114type: from 0.86 [0.75e0.93] to 0.69 [0.57e0.83]) and remained
constant afterward. Genotypes demonstrated no major differences
in individual PC or LPC levels, as represented by the PC/LPC pairs in
Fig. 2(A). Similarly, the switch to HFD was directly reﬂected in a
decline of the sums of omega-6 as well as omega-3 FFA as a per-
centage of total FFA in both groups. However, both groups showed
signiﬁcant increases in total omega-3 FFA at end-point, while total
omega-6 FFA levels remained constant (data not shown). This was
reﬂected in the omega-6/omega-3 FFA ratio, another lipid marker
of general inﬂammatory state, which decreased signiﬁcantly over
time with no differences between groups (data not shown). Indi-
vidual oxylipin changes were similar between genotypes. The
arachidonic acid (AA) metabolite 5,6-epoxyeicosatrienoic acid (5,6-
EET) and its stable hydrolysis product 5,6-dihydroxyeicosatrienoicPlease cite this article in press as: Kozijn AE, et al., Human C-reactive prot
Osteoarthritis and Cartilage (2018), https://doi.org/10.1016/j.joca.2018.09acid (5,6-DHET) increased over time [Fig. 2(B)]. Oxidized linoleic
acid (LA) metabolites showed a decrease over time, as represented
by 13-hydroxyoctadecadienoic acid (13-HODE, Fig. 2(B)). The DHA-
metabolite 17-hydroxy docosahexaenoic acid (17-HDHA) increased
over time [Fig. 2(B)].
Increased monocyte activation in hCRP-tg mice on a HFD
Peripheral myeloid and lymphoid populations were analysed
by ﬂow cytometry at three different time points (t ¼ 2, 11 and 37
weeks) to evaluate the direct and prolonged systemic effects of
HFD feeding on immune status (Supplemental Figs. S3 and S4).
Baseline population frequencies were determined in age-matched
hCRP-tg (n ¼ 5) and wild-type (n ¼ 4) males from later litters andein aggravates osteoarthritis development in mice on a high-fat diet,
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Fig. 2. Transgenic and wild-type hCRP males show similar plasma lipid proﬁles on a HFD. A) Representative PC/LPC pairs show increases in fasted plasma levels in both study groups
during the HFD regimen. B) Representative oxylipins from the three most important oxylipin substrates (i.e., AA, LA and DHA) demonstrate distinct concentration changes in fasted
plasma during the HFD regimen. Boxplots show boxes extending from the 25th to 75th percentiles containing the median (middle line), with error bars down to the minimum and
up to the maximum value. The individual value for each animal is plotted as a dot superimposed on the graph. IS, internal standard; PC, phosphatidylcholine; LPC, lysophos-
phatidylcholine; EET, epoxyeicosatrienoic acid; DHET, dihydroxyeicosatrienoic acid; HODE, hydroxyoctadecadienoic acid; HDHA, hydroxy docosahexaenoic acid; AA, arachidonic
acid; LA, linoleic acid; DHA, docosahexaenoic acid.
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grey).
HFD feeding induced similar immune reactivity within
lymphocyte populations of hCRP-tg and wild-type males (data
not shown), but triggered distinct changes in the circulating
monocyte populations of these groups. Firstly, HFD feeding
nearly doubled the total percentage of circulating CD11bþ
monocytes in both groups (30.43 ± 5.26 at week 2 vs
53.85 ± 10.35 at week 37, Fig. 3(A)). Secondly, the hCRP-tg mice
showed signiﬁcant upregulation of activated non-classical GR-
1low monocytes expressing both the integrin CD11c and chemo-
kine receptor CCR2 after 2 weeks of HFD feeding (Fig. 3(B),
P ¼ 0.02, d ¼ 0.82, 95% CI [0.70e6.33]). Co-expression of the
lymphocyte activation antigen CD86 on GR-1lowCCR2þ mono-
cytes was elevated upon long-term HFD feeding, with hCRP-tg
males showing a signiﬁcantly increased co-expression
compared with wild-type controls (Fig. 3(C) (P ¼ 0.02,
d ¼ 0.79, 95% CI [0.73e8.07]) and Fig. 3(D) (P ¼ 0.02, d ¼ 0.82,
95% CI [0.79e7.39])). Correspondingly, percentages of GR-1lowFig. 3. Increased activation of classical and non-classical monocytes in hCRP-tg mice. A) Dist
groups over time. Baseline population frequencies were determined in age-matched hCRP-
statistical analysis (shown here in grey). B) GR-1low non-classical monocytes showed an
signiﬁcantly elevated in hCRP-tg compared with wild-type mice. C-D) GR-1low non-classical
long-term HFD feeding (37 weeks), with hCRP-tg males showing higher co-expression
monocytes co-expressing CCR2 and CD86 increase over time and were signiﬁcantly more pre
group means (indicated by bars) with SD (error bars). *P < 0.05 compared with wild-type
Please cite this article in press as: Kozijn AE, et al., Human C-reactive prot
Osteoarthritis and Cartilage (2018), https://doi.org/10.1016/j.joca.2018.09monocytes without CCR2 expression were signiﬁcantly
decreased in hCRP-tg males compared with wild-types at 2
weeks (data not shown). Over time, hCRP-tg mice showed an
increase in activated classical GR-1highCCR2þCD86þ monocytes
compared with wild-type controls (Fig. 3(E), P ¼ 0.04, d ¼ 0.71,
95% CI [0.06e1.64]).
To evaluate the association between genotype and OA devel-
opment on the changes in circulating immune cell populations,
linear mixed modelling was used (Supplemental Fig. S5). In hCRP-
tg mice the percentages of CD11bþ leukocytes were associated
with lateral OA severity, while in wild-type littermates this corre-
lation was inversed. Correspondingly, CD11b cell populations
signiﬁcantly decreased with increasing lateral OA severity in hCRP-
tgmice and vice versa for wild-type controls. The hCRP-tg genotype
was also signiﬁcantly associated with higher percentages of both
classical CD11bþGR-1high and non-classical CD11bþGR-1low mono-
cytes with increasing lateral OA severity. Wild-type controls
showed an inverse relationship between these monocyte subsets
and lateral OA severity.ribution of peripheral CD11bþ immune cells shows HFD-mediated monocytosis in both
tg (n ¼ 5) and wild-type (n ¼ 4) males from later litters and were not included in the
increase in CCR2 and CD11c expression upon 2 weeks of HFD feeding, which was
monocytes expressing CCR2 upregulated the lymphocyte activation antigen CD86 after
of these activation markers compared with wild-type controls. E) GR-1high classical
sent in hCRP-tg compared with wild-type males at t ¼ 37 weeks. Data are presented as
controls.
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A.E. Kozijn et al. / Osteoarthritis and Cartilage xxx (2018) 1e11 7Human CRP has no effect on synovial macrophage accumulation
and phenotype shift
As systemic CRP levels have been found to reﬂect local joint
inﬂammation in patients with advanced OA14, knee joints were
evaluated for the local presence of M1 and M2 macrophage subsets
in the synovial lining layer. Macrophages were detected by the pan-
macrophage marker F4/80 and subsets were discriminated by
colocalization of inducible nitric oxide synthase (iNOS) for M1
macrophages and the mannose receptor (CD206) for M2
macrophages.Fig. 4. Human CRP has no effect on synovial macrophage accumulation and subsets. A) Rep
showing pan-macrophage marker F4/80 (green), M1 subset marker iNOS (blue) and M2 subs
40. B) Percentage of the surface area within the ROI or within the F4/80þ cell fraction for h
phenotypes. Data are presented as group medians (indicated by bars) with IQR (error bars
Please cite this article in press as: Kozijn AE, et al., Human C-reactive prot
Osteoarthritis and Cartilage (2018), https://doi.org/10.1016/j.joca.2018.09Overall, both upon microscopical evaluation and image analysis,
there were no signiﬁcant differences found for synovial macro-
phage populations between genotypes [Fig. 4(A)]. Univariate
testing hinted towards increased CD206 positivity and CD206/iNOS
colocalization in knee joints from hCRP-tg males (P ¼ 0.122 and
P ¼ 0.183 respectively, MWU-test; Fig. 4(B)).
Discussion
High CRP levels found in metabolic syndrome patients have
been suggested to actively contribute to inﬂammatory morbiditiesresentative unmixed spectral images of the lateral patellofemoral synovial lining (ROI)
et marker CD206 (magenta) positivity. Magniﬁcation for the top microphotographs was
CRP-tg and wild-type mice, showing no CRP-induced shift in macrophage numbers and
).
ein aggravates osteoarthritis development in mice on a high-fat diet,
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A.E. Kozijn et al. / Osteoarthritis and Cartilage xxx (2018) 1e118and related increased cardiovascular and diabetic risks25. In the
current study we demonstrate that hCRP-tg mice developed more
severe OA compared with their wild-type controls under the same
HFD regime. Although obesity-related low-grade systemic inﬂam-
mation is recognized as a contributing factor in metabolic OA
pathogenesis, associations between CRP levels and OA features
rendered contradictory results between cohort studies. Here we
show that hCRP-tg mice exhibit increased cartilage degradation
and osteophytosis, but not increased synovitis. The latter is
generally seen as a typical inﬂammatory component of OA, which
may partly underlie the conﬂicting ﬁndings in the different cohort
studies. Our study, in which the expression of CRP was the only
variable, implicates CRP as an independent trigger to aggravate
HFD-induced OA development.
The positive association between metabolic syndrome and CRP
levels in humans26 and the exacerbation of metabolic disorders in
hCRP-tg mice27,28 suggest CRP is more than merely an inﬂamma-
tion marker in metabolic disorders. In hCRP-tg mice, as in humans,
the CRP protein is synthesized by hepatocytes only and is regulated
at the transcriptional level29. Conﬁrming previous observations8,
HFD feeding evoked a direct and prolonged rise in plasma CRP
levels in hCRP-tg males from our study, indicative of a systemic
inﬂammatory status. Possibly, CRP induces cascades that are not
raised in wild-type C57BL/6J mice or ampliﬁes the activation of
inﬂammatory pathways that are not triggered by HFD alone.
While a widely used clinical marker of general inﬂammation,
the physiological functions of human CRP remain to be fully
elucidated and can be pro- or anti-inﬂammatory depending on the
situation. One major route of action is the involvement of CRP in
innate immunity through the opsonisation of pathogens or dying
cells and subsequent activation and modulation of complement via
binding to C1q30. Even though no added effect to synovitis severity
was observed, an increased inﬂammatory pathway because of CRP
signalling still seems likely as osteophyte formation is linked to
inﬂammation31,32. It is well possible that CRP is driving a speciﬁc
inﬂammatory pathway that is associated with osteophyte devel-
opment. Angiogenesis at the osteochondral junction could be such
a process, which has been demonstrated to lead to endochondral
ossiﬁcation and the formation of osteophytes33. Human CRP has
been shown to upregulate vascular growth factor (VEGF) expres-
sion34, a driver of neovascularization which is expressed by hy-
pertrophic chondrocytes and synovial macrophages, and VEGF
inhibition is suggested as a treatment strategy for OA35. Involve-
ment of synovial macrophages is not supported by our results, but
perhaps hypertrophic chondrocytes can play a role under the
experimental conditions applied.
Inﬂammation is closely linked to lipid metabolism, a conjunc-
tion particularly noticeable in metabolic diseases. As obesity and
metabolic syndrome are important risk factors for OA and induce
elevated CRP levels in patients, we postulated that obese hCRP-tg
males might demonstrate a more proinﬂammatory lipid proﬁle
compared to their controls. Indeed, HFD-induced effects were
evident for nearly all lipids measured and indicated low-grade
systemic inﬂammation. However, these changes were not signiﬁ-
cantly different between genotypes nor correlated to any of the
observed OA features. It is possible that the added effect of CRP at
the individual lipid level was overshadowed by the profuse sys-
temic inﬂuence of the HFD itself.
Alternatively, it is arguable that CRP could have affected OA
development locally. This is supported by de Visser et al. in a rat
model of metabolic OA, where local changes in synovial ﬂuid
oxylipin concentrations were not equally translated into systemic
changes for the same oxylipins measured in plasma36. A route
through which CRP could be involved in lipid-driven local cartilage
changes is via OA-induced upregulation and activation ofPlease cite this article in press as: Kozijn AE, et al., Human C-reactive prot
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are able to dissociate pentameric CRP to its pathogenic monomeric
(m)CRP subunits37. Increased PLA2 activity has been demonstrated
in the synovial ﬂuid of OA patients and animal models of OA38e40.
Devoid of synovial ﬂuid samples, we attempted to explore PLA2
activity in our lipidomic data from fasted plasma samples. Unfor-
tunately, systemic lipid concentrations rendered some conﬂicting
results concerning PLA2 activity. As PLA2 enzymes mainly convert
PC to LPC, the decrease in systemic LPC/PC ratio in our HFD-fed
mice suggests a lower activation of PLA2. Hydrolysis of PC to LPC
by PLA2 enzymes produces a FFA, which is frequently the omega-6
fatty acid arachidonic acid (ARA)41. In this respect, the observed
increase in omega-6/omega-3 FFA ratio substantiates decreasing
PLA2 activity. However, the increases in ARA and its metabolites
point to an increased activation of PLA2. Combined enzymatic ac-
tivities of PLA2 enzymes and cyclooxygenase (COX)-2 generate
prostaglandins from ARA and members of this pathway have been
implicated in OA pathogenesis42,43. Although sample volumes were
insufﬁcient to measure prostaglandin E2 (PGE2) levels, we did
observe an increase in prostaglandin PGD2 concentration over time
e further corroborating increased PLA2 activity. Clearly, the in vivo
effects of the lipid metabolism on the inﬂammatory milieu are
complex and circulating lipids do not provide the best read-out in
our current model.
The physiological role of CRP may be just as complex, with its
multiple active isoforms and manifold physiological functions in
various biological systems. Even though CRP predates the adaptive
immune system by millions of years, it was found to bridge innate
with adaptive immunity by binding to Fcg receptors on immune
cells like monocytes44. Both hCRP-tg and wild-type mice showed
expansion of the systemic monocyte fraction upon HFD feeding,
consistent with previous ﬁndings45. However, we found that hCRP-
tg monocytes expressed more activation markers like CD11c, CCR2
and CD86. The integrin CD11c was predominantly expressed by
activated CD11bþGR-1lowCCR2þ monocytes, which are known to
upregulate CD11c as an adhesive ligand during monocyte recruit-
ment in shear ﬂow46. This suggests that non-classical, patrolling
GR-1low monocytes were more actively recruited to the tissues of
hCRP-tg mice compared with wild-type controls. In addition, hCRP-
tg mice showed an increase in activated CD11bþGR-1high-
CCR2þCD86þ classical monocytes, indicative of an enhanced in-
ﬂammatory state. This latter observation might be linked to
metabolic OA development, as the increased percentages of CD11bþ
immune cells and monocyte subsets in the hCRP-tg genotype were
positively associated with increasing lateral OA severity. Wild-type
controls showed inverse associations, strengthening the involve-
ment of CRP in the activation of these immune populations.
The systemic activation of myeloid cells was not reﬂected in the
knee joint, where synovial macrophage subsets were comparable
between hCRP-tg and wild-type littermates. This is consistent with
the similar synovitis scores found in both groups. Our ﬁndings add
to recent reports on HFD-induced OA in mice on a C57BL/6J back-
ground, where macrophage depletion aggravated cartilage degen-
eration following injury47 and resident adipose tissue macrophages
retained their M2-like phenotype in the infrapatellar fat pad48.
Together, these ﬁndings emphasize the persistence and therefore
the importance of local macrophage populations in regulating ho-
meostasis in the osteoarthritic knee joint. The combination of
monocyte recruitment and unchanged resident macrophage pop-
ulations in our study show similarities to observations in a mouse
model of inﬂammatory arthritis49. Here, tissue-resident synovial
macrophages showed no changes in phenotype or number and
expressed markers of M2 polarization over the course of arthritis.
However, the authors showed that non-classical monocytes
recruited from circulation orchestrated the initiation and resolutionein aggravates osteoarthritis development in mice on a high-fat diet,
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phages respectively. Perhaps the hint towards an overall increase in
CD206 expression in the synovium indicates monocyte presence, as
activated monocytes are able to upregulate CD206 expression50.
This monocytic plasticity and the role of human CRP herein
warrant further research in the context of metabolic OA.
Although the functional involvement of CRP in OA pathogenesis
remains uncertain, our study shed some light on the biological pro-
cesses involved. This uncertainty is inherent to the gain-of-function
model we employed, as overexpression phenotypes often fail to
faithfully reﬂect thephysiological function(s) of a protein51. A loss-of-
function model would have provided more straightforward inter-
pretable results. However, unlike human CRP, mouse CRP is a minor
acute-phase reactant and is synthesized in only trace amounts52,53.
Human CRP, when transferred into mice, behaves as it does in man:
its expression is highly inducible and tissue-speciﬁc29. We believe
that this signiﬁcant difference in the transcriptional control of CRP
synthesis in humans and mice justiﬁes the use of our model for
studyinghumanCRP. Still, extrapolation frommouse toman requires
caution. Validationof ourﬁndingsonperipheralmonocyte subsets in
obeseOApatientswithhighand lowCRP levels is required to conﬁrm
the role CRP inOApathogenesis. An additional potential limitation of
our study is that chowcontrolswere not included in our study, aswe
focused on CRP involvement in OA and previous work by our group
has shown that HFD feeding in hCRP-tg males led to severe OA
development compared with chow-fed hCRP-tg males8.
The present study implicates CRP as an independent trigger for
the aggravation of metabolic OA by increasing cartilage degenera-
tion and osteophytosis. Increased recruitment of classical and non-
classical monocytesmight be amechanism of action throughwhich
CRP is involved in aggravating this process. Based on our data,
involvement of CRP in lipid metabolism and synovial macrophage
activation seems unlikely. Although the mechanism of action for
CRP involvement in OA is not yet resolved, it is clear that we are
selling CRP short when solely considering it a general systemic
inﬂammation marker in metabolic OA. Our ﬁndings suggest that
interventions selectively directed against CRP activity could
ameliorate metabolic OA development.
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